Hannah Valantine

Publication Details

  • New developments in immunosuppressive therapy for heart transplantation.

    Khush KK, Valantine HA. Expert Opin Emerg Drugs. 2009; 14 (1): 1-21

    Heart transplantation is a well-established therapeutic option for many patients with end-stage heart disease. A major challenge in heart transplantation today is providing effective immunosuppression to prevent graft rejection while minimizing the many adverse effects of currently available therapies.

    PubMedID: 19265486

Stanford Medicine Resources:

Footer Links: